100
Participants
Start Date
January 31, 2001
Primary Completion Date
April 30, 2002
Study Completion Date
April 30, 2002
AVP-923
Columbia-Presbyterian Center Neurological Institute, New York
State University of New York, Syracuse
MCP-Hahnemann University Dept. of Neurology, Philadelphia
Penn Neurological Institute, Philadelphia
Johns Hopkins University, Baltimore
Wake Forest University, Winston-Salem
Carolinas Medical Center Carolinas Neuromuscular/ALS-MDA Center, Charlotte
University of Miami Dept. of Neurology, Miami
Cleveland Clinic Foundation, Cleveland
University of Wisconsin ALS Clinical Research Center, Madison
Northwestern Medical School, Chicago
University of Texas Health Science Center @ San Antonio, San Antonio
University of Colorado Health Sciences, Denver
UCLA School of Medicine Dept. of Neurology, Los Angeles
Loma Linda University Dept. of Neurology, Loma Linda
University of California, San Francisco, San Francisco
Massachusetts General Hospital, Boston
Lead Sponsor
Avanir Pharmaceuticals
INDUSTRY